PTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine in whole blood. Creatinine measurements are used in the diagnosis and treatment of renal (kidney) diseases and in the monitoring of renal dialysis. This system is intended for the professional use for accurately and reproducibly measuring creatinine in human whole blood obtained from a finger stick sample
Published July 4, 2012 · Recall initiated: May 15, 2012
Summary
FDA records medical device Class II recall Z-1903-2012, published July 4, 2012 and initiated May 15, 2012. Recalling firm: Polymer Technology Systems, Inc.; Status: Terminated; Reported quantity: 1650 vials; Lot: Cat No. 1720; and Lot number F103. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Polymer Technology Systems, Inc.
- Distributor
- Worldwide Distribution -- Nationwide Distribution including the states of CA and VA., and the countries of China, Poland, Ireland and France.
- Lot
- Cat No. 1720; and Lot number F103
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAPTS Diagnostics CardioChek Plus Professional Analyzer, New analyzer, boxed, with carrying case, ReferenceJanuary 29, 2020
- FDAPTS Panels CHOL+HDL+GLU Test Strips, Reference Number 5412, for use on CardioChek PA or CardioChek PlusJanuary 1, 2020
- FDALipid Panel test strips (as a component of smart bundles), REF 2729, also private labeled under Henry ScheinMay 29, 2019
- FDACHOL+HDL+GLU test strips, REF 2412May 29, 2019
- FDAMULTIGENT Acetaminophen for use with Architect/Aeroset Cat. No. 2K99-20. Assay is intended for theJuly 4, 2012
- FDAARCHITECT CA 19-9XR Reagent Kit; ARCHITECT CA 19-9 Reagent Kit, list 291-20 (4 x 100 tests), 2K91-25 andJuly 4, 2012
Questions about this recall
Was PTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine in whole blood. Creatinine measurements are used in the diagnosis and treatment of renal (kidney) diseases and in the monitoring of renal dialysis. This system is intended for the professional use for accurately and reproducibly measuring creatinine in human whole blood obtained from a finger stick sample recalled?
Yes. FDA published recall Z-1903-2012 on July 4, 2012. Reported hazard: During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.
What should I do if I have this product?
Voluntary: Firm initiated · Letter